Literature DB >> 17442798

Genetic and antigenic analysis of invasive serogroup Y Neisseria meningitidis isolates collected from 1999 to 2003 in Canada.

Raymond S W Tsang1, Averil M Henderson, Marissa L Cameron, Shaun D Tyler, Shari Tyson, Dennis K S Law, Jan Stoltz, Wendell D Zollinger.   

Abstract

One hundred forty serogroup Y Neisseria meningitidis isolates recovered from patients with invasive meningococcal disease (IMD) in Canada from 1999 to 2003 were analyzed by genetic and serological methods. Seventy-four isolates (52.9%) belonged to serotype 2c, and most have serosubtype antigen P1.5,2 (37 isolates, 26%) or P1.5 (31 isolates, 22%). Forty-eight isolates (34.3%) belonged to serotype 14 and have serosubtype antigen P1.5,2 (13 isolates, 9%) or P1.5 (7 isolates, 5%) or were nonserosubtypeable (27 isolates, 19%). Thirteen isolates (9.3%) were nonserotypeable. Multilocus sequence typing identified two unrelated clonal populations of serogroup Y meningococci causing invasive disease in Canada: ST-23 and ST-167 clonal complexes. Almost all ST-167-related isolates were typed as 2c:P1.5, while strains of the ST-23 clonal complex were either serotype 14 or 2c but with the serosubtype antigen P1.5,2. In contrast to previous reports that patients with serogroup Y disease are usually older, 26% of the Canadian serogroup Y cases were found in the 10-to-19-year-old age group and another 11% were in the 20-to-39-year-old age group.

Entities:  

Mesh:

Year:  2007        PMID: 17442798      PMCID: PMC1933026          DOI: 10.1128/JCM.02134-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  34 in total

Review 1.  Meningococcal disease.

Authors:  N E Rosenstein; B A Perkins; D S Stephens; T Popovic; J M Hughes
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

2.  Distribution of serogroups of Neisseria meningitidis and antigenic characterization of serogroup Y meningococci in Canada, January 1, 1999 to June 30, 2001.

Authors:  Raymond Sw Tsang; Susan G Squires; Wendell D Zollinger; Fraser E Ashton
Journal:  Can J Infect Dis       Date:  2002-11

Review 3.  Meningococcal molecular mimicry and the search for an ideal vaccine.

Authors:  J M Griffiss; R Yamasaki; M Estabrook; J J Kim
Journal:  Trans R Soc Trop Med Hyg       Date:  1991       Impact factor: 2.184

4.  siaD PCR ELISA for confirmation and identification of serogroup Y and W135 meningococcal infections.

Authors:  R Borrow; H Claus; U Chaudhry; M Guiver; E B Kaczmarski; M Frosch; A J Fox
Journal:  FEMS Microbiol Lett       Date:  1998-02-15       Impact factor: 2.742

5.  Antigenic shift and increased incidence of meningococcal disease.

Authors:  Lee H Harrison; Keith A Jolley; Kathleen A Shutt; Jane W Marsh; Mary O'Leary; Laurie Thomson Sanza; Martin C J Maiden
Journal:  J Infect Dis       Date:  2006-03-28       Impact factor: 5.226

6.  Genomic fingerprinting of Neisseria meningitidis associated with group C meningococcal disease in Canada.

Authors:  C A Strathdee; S D Tyler; J A Ryan; W M Johnson; F E Ashton
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

7.  Dosage escalation, safety and immunogenicity study of four dosages of a tetravalent meninogococcal polysaccharide diphtheria toxoid conjugate vaccine in infants.

Authors:  Margaret Rennels; James King; Robert Ryall; Thomas Papa; James Froeschle
Journal:  Pediatr Infect Dis J       Date:  2004-05       Impact factor: 2.129

8.  Proposed standardization of Neisseria meningitidis PorA variable-region typing nomenclature.

Authors:  C T Sacchi; A P Lemos; M E Brandt; A M Whitney; C E Melles; C A Solari; C E Frasch; L W Mayer
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

Review 9.  Meningococcal disease: still with us.

Authors:  H Peltola
Journal:  Rev Infect Dis       Date:  1983 Jan-Feb

10.  Molecular epidemiology and emergence of worldwide epidemic clones of Neisseria meningitidis in Taiwan.

Authors:  Chien-Shun Chiou; Jui-Cheng Liao; Tsai-Ling Liao; Chun-Chin Li; Chen-Ying Chou; Hsiu-Li Chang; Shu-Man Yao; Yeong-Sheng Lee
Journal:  BMC Infect Dis       Date:  2006-02-15       Impact factor: 3.090

View more
  12 in total

1.  Invasive meningococcal disease caused by Neisseria meningitidis strains expressing both serogroup Y and W-135 antigenic specificities.

Authors:  Karen M Rudolph; Carolynn DeByle; Alisa Reasonover; Tammy Zulz; Dennis K S Law; Jianwei Zhou; Raymond S W Tsang
Journal:  J Clin Microbiol       Date:  2010-11-10       Impact factor: 5.948

2.  Advice for Consideration of Quadrivalent (A, C, Y, W135) Meningococcal Conjugate Vaccine, for use by Provinces and Territories.

Authors: 
Journal:  Can Commun Dis Rep       Date:  2010-01-26

3.  Profile of serogroup Y meningococcal infections in Canada: Implications for vaccine selection.

Authors:  Nicole Le Saux; Julie A Bettinger; Susan Wootton; Scott A Halperin; Wendy Vaudry; David W Scheifele; Raymond Tsang
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

4.  Genotypic comparison of invasive Neisseria meningitidis serogroup Y isolates from the United States, South Africa, and Israel, isolated from 1999 through 2002.

Authors:  Anne M Whitney; Garry B Coulson; Anne von Gottberg; Colin Block; Nathan Keller; Leonard W Mayer; Nancy E Messonnier; Keith P Klugman
Journal:  J Clin Microbiol       Date:  2009-07-01       Impact factor: 5.948

Review 5.  The changing epidemiology of meningococcal disease in North America 1945-2010.

Authors:  Carmen Baccarini; Andrew Ternouth; Heather Wieffer; Andrew Vyse
Journal:  Hum Vaccin Immunother       Date:  2012-10-29       Impact factor: 3.452

6.  Bacteraemic pneumonia caused by Neisseria meningitidis serogroup Y.

Authors:  Maria Pilar Romero-Gomez; Zaida Rentero; Jose Ramon Paño; Jesus Mingorance
Journal:  Respir Med Case Rep       Date:  2011-12-26

7.  Evolution of meningococcal carriage in serogroups X and Y before introduction of MenAfriVac in the health district of Kaya, Burkina Faso.

Authors:  Absatou Ky Ba; Idrissa Sanou; Paul A Kristiansen; Lassana Sangaré; Rasmata Ouédraogo; Kalifa Ouattara; Maxime Kienou; Simon Tiendrebeogo; Juliette Tranchot
Journal:  BMC Infect Dis       Date:  2014-10-14       Impact factor: 3.090

8.  Serogroup Y meningococcal disease, Colombia.

Authors:  Clara Inés Agudelo; Olga Marina Sanabria; María Victoria Ovalle
Journal:  Emerg Infect Dis       Date:  2008-06       Impact factor: 6.883

9.  Meningococcal disease: changes in epidemiology and prevention.

Authors:  Qiuzhi Chang; Yih-Ling Tzeng; David S Stephens
Journal:  Clin Epidemiol       Date:  2012-09-19       Impact factor: 4.790

10.  WGS analysis of a penicillin-resistant Neisseria meningitidis strain containing a chromosomal ROB-1 β-lactamase gene.

Authors:  Raymond S W Tsang; Tauqeer Ahmad; Frances B Jamieson; Gregory J Tyrrell
Journal:  J Antimicrob Chemother       Date:  2019-01-01       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.